InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
0.00%
)
US TECH 100
17,016.80
(
0.93%
)
Dow Jones
37,903.29
(
0.00%
)
Brent Oil
84.07
(
0.63%
)
Bitcoin
58,695.84
(
0.79%
)
Post# of 3854
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GOIN/Green

Send PM Follow Ignore
Followers 14
Posts 1044
Boards Moderated 0
Alias Born 02/28/2017

GOIN/Green

Re: None

Tuesday, 03/05/2019 9:19:46 AM

Tuesday, March 05, 2019 9:19:46 AM

Post# of 3854
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
-- Patent covers use of cannabinoids and terpenes for treatment of
organophosphate and carbamate toxicity --

https://files.constantcontact.com/8d9857b2301/60a4bdcb-e585-45ee-8710-b2474cc6a8ee.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NXEN News
More NXEN News
InvestorsHub NewsWire

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!